Showing posts with label drug information. Show all posts
Showing posts with label drug information. Show all posts

Tuesday, February 5, 2019

Rotation 4, 5, 6: Drug Information, Critical Care, General Medicine

Posted by Andrea at Tuesday, February 05, 2019

Rotation 4: Drug Information

This rotation was with a drug information company and I was able to work remotely, as my preceptor also works remotely. We met two to three times a week for about one hour and communicated often during the week via email. My responsibilities were to write monographs for drug-drug interactions and drug-gene interactions (e.g. CYP2D6, CYP4A4, etc.). This consisted of reading lots of articles, learning how to scour PubMed for literature, and writing concise summaries.

Time management was incredibly important in this rotation. I had the freedom to create my own schedule each day, but this also allows for time to slack off. I had to hold myself accountable and ensure I completed my work. I learned a lot about what goes into writing the monographs when we search our drug information resource for quick answers about drugs and interactions. I always thought I would enjoy working by myself, so I was surprised that I missed interacting with co-workers and patients daily. Looking forward, I hope to find a position that balances independent work with teamwork or direct patient care.

Rotation 5: Critical Care

This rotation was in the surgical intensive care unit (SICU) at a local community teaching hospital. Going into this, I was nervous and intimidated by the complexity of critical care patients. My typical day started with working up patients (6AM-9AM), round with the team (9AM-11AM), eat lunch and finish working up patients (11AM-12PM), then meet with my preceptor (12PM-1PM). After this, I would work on assigned drug information questions or projects for the rest of the day. Working up patients in the ICU is based on the head to toe systems approach, rather than problem based like how we learned in class. This means problems were categorized by systems, which could include neurological, pulmonary, cardiovascular, GI/FEN (fluids, electrolytes, nutrition), I/O (ins and outs), ID, and heme. Patients were very sick and often had multiple problems within each system listed above.

I am very grateful to have had this rotation. I have a much better understanding of anatomy and how surgical changes can affect drug action/metabolism in the body. I also learned about weaning patients off pressors, opioid conversions, and nutrition. I had the opportunity to work with a large team, which consisted of an attending, fellow, residents, medical students, and dietitian. I also enjoyed working with my preceptor who was a great teacher and with another pharmacy student from a nearby school! Overall, this was a great learning experience and I am glad I was able to try it out.

Rotation 6: General Medicine (Adult Internal Medicine)

All P4 students are required to take the Gen Med rotation and I was placed on the Adult Internal Medicine service. This was a busy rotation, due to the patient load and weekly projects. My service capped at 11 patients and by the end of the rotation, I was managing the entire service. Patients had a variety of disease states, including pneumonia, UTIs, atrial fibrillation, and diabetes. The typical day started with working up patients (5AM-7:30AM), pre-round with my preceptor where I would present patients and run my recommendations by him (7:30AM-8AM), round with the team (8AM-11AM), and post-rounds with my preceptor where I would update him with any changes (11AM-11:30AM). The rest of the day was spent educating patients discharged on anticoagulation, meeting with my preceptor to go over patients or topics, and meeting with the other students also on Gen Med to present our projects. Time management and efficiency are key to this rotation and each student will develop their own schedule or system that works for them.

Pharmacists play an important role in antimicrobial stewardship and anticoagulation management on this service. I enjoyed the variety of patients and activities in this rotation. I was constantly learning and it made the long days fly by. My advice to students is to embrace this rotation and challenge yourself to learn as much as you can!


This rotation ended just before the holidays and I am currently on my off block. After this, only 2 more rotations until graduation!

Gen Med Block 6 students wearing our ugly Christmas sweaters!

Friday, October 5, 2018

Rotation 4: Drug Information

Posted by Unknown at Friday, October 05, 2018

During the last 5 weeks, I had the opportunity to work with a well known drug information company and had a great experience!

Before the rotation started, I talked to multiple people who had this rotation in the past and came in with some specific expectations. While my expectations pretty much held up (time requirement, workload, preceptor style), I learned it is important to continue keeping an open mind going into any rotation no matter what you were told by others.

First, I'll let you know that this is one of the only rotations where you get to work from home!! It was amazing and I really enjoyed setting my own schedule and working at my pace! That being said, you have to manage your time well and hold yourself accountable to getting all the work done. I met with my preceptor (and fellow classmate on rotation with me) three times a week. These meetings were between 20 minutes and 1 hour and were helpful in keeping me on track with the rotation work. My preceptor was a great resource and was very receptive to questions and suggestions. She also gave great feedback and really helped refine my skills.

My preceptor worked in the drug interaction section of the company, so we worked on updating and creating drug interaction monographs. After this rotation, I feel a lot more comfortable doing PubMed searches because of all the searching I did for this rotation! I know I will take the skills I learned in this rotation and bring them with me wherever I go! I also learned how to write concise, one sentence summaries of clinical studies for the monographs. This is a very specific kind of writing and I think it will be helpful in the future when I am writing papers and in residency. I also got to explore topics I didn't know much about during three longitudinal projects (drugs that prolong QTc, possible UGT1A1 inducers/inhibitors and interactions with smoking).

I feel really proud of the work I did this rotation. There are people all over the world who will use the monographs I created to help patients! I can go and lookup the drug interaction (e.g., omeprazole and ginkgo biloba) and see one of the monographs I created! I feel so excited thinking that I contributed something so practical and widely used to the field of pharmacy and medicine!

Two things to remember:
-Keep an open mind going into any experience and put your best foot forward!
-Make sure you take time and enjoy this beautiful life, no matter how busy it gets!

Exploring Maine: Acadia National Park (top) and Baxter State Park (bottom)

Tuesday, January 24, 2017

Rotation 7: Lexicomp and Work From Home

Posted by Unknown at Tuesday, January 24, 2017

I was very thankful that I received not only Lexicomp, but also with Steven Stout, someone with a technical background and someone immersed in the database management aspect of keeping this enormous drug information resource online.

Unlike most rotations, Lexicomp is a work-from-home. Typically, I met with my preceptor 2-3 times per week in various coffee shops in the Ann Arbor area for discussion of the work done so far, where to go from here, and do mini "topic-discussions" on topics related to the collection and organization of drug information resources. This includes statistics, study design, database design, information sources, how to vet information sources, searching (search terms, structure, narrowing results), and many, many more.

Work centers around the searching, collection, organization, and drafting of drug interaction monographs for inclusion in the Lexicomp Interactions database, as well as taking part in a number of longitudinal projects that his team is involved with. This includes migration to a new content management system and the thousands of tasks involved in that process, developing a tool that creates graphical summaries of queries to the OpenFDA API, among others.

This has been a very flexible rotation--work does not need to be done in an eight hour block so long as it gets done and during interview season (onsites for fellowships) this has been an incredible benefit as I can do work on the plane or in an airport or in a hotel in Seattle. That said, you will be tested on your time management skills as there is no external forces making you do anything! Self-motivation is a big plus!

One of the biggest benefits (as pointed out by other commentators) is the incredibly refinement of your literature search abilities. I had been doing this in a managed care setting for two years and still made leaps and bounds in my ability to careful craft queries (MeSH terms are the best) and iteratively refine my searches to maximize my relevant results. There have been many "mind-blown" moments when using PubMed, EMBASE, and other databases with these techniques, particularly when comparing how I used to construct a term versus my current method.

What has been incredibly cool is seeing the nuts and bolts of Lexicomp Interactions—how everything fits together and the methods that they use to keep their enormous quantity of data organized and maintained. My preceptor is truly a master of the craft and he has been an incredible mentor in developing some of my own skills in this area as well.

A typical day is what you make it, and there is tremendous flexibility in pursuing projects relevant to your interests! Highly recommended!

Michael Harrison (mhar)



Five Weeks at Eli Lilly: A Non-Traditional Experience

Posted by Unknown at Tuesday, January 24, 2017

With the majority of my clinical experiences under my belt, come October it was time to drive the four hours to Indianapolis to begin my rotation at one of the world’s largest pharmaceutical companies.

Lilly, like most large companies, specializes in a handful of therapeutic areas: oncology (gemcitabine, pemetrexed, cetuximab, among others), neuroscience (the largest Alzheimer's development program on Earth), diabetes (Humalog, Humalin), and bio-medicines. The Bio-medicines unit covers a handful of smaller focus areas, including men's health, cardiovascular, pain, and others. While they have a global presence, their headquarters in Indianapolis also houses most of their production facilities, which I will discuss more later. For more background on Lilly, here is their Wikipedia page.

I had no idea what to expect going in--my preceptor is a clinical research scientist in Early Phase Oncology Clinical Development. I would quickly discover what that means!

Day 1:

I stayed about 20 minutes from Lilly's technology campus (about a 10 minute drive from their headquarters) at a friend's house whose family generously offered to allow me to stay with them (great coincidence!). The day began with a few hours of onboarding (filling out paperwork, safety training, etc.) after which I drove to the main campus to meet my preceptor.

All of the buildings on the main campus are connected underground, including the parking garages! The campus is massive--with restaurants, dry cleaning, a bank, a gym, track, and soccer fields, and other amenities on-site. We spent most of the morning discussing my preceptor's role and where I would be fitting in. It breaks down like this:

My preceptor is a clinical research scientist. As a PharmD in this role, he is responsible for the day-to-day operations of his clinical trials. This could mean ensuring enrollment is on-track, monitoring incoming safety and efficacy data (blinded!), and importantly, answering clinical questions from the providers at the research sites regarding eligibility, enrollment, side-effects, clinical management, and anything and everything in between for any of the sites scattered around the world.

Outside of the Phase III trial he is responsible for, he is required to put on his early phase hat from time to time. This might mean working with the pre-clinical development group to identify promising leads or providing recommendations for unmet medical needs that could drive a new project, authoring study reports, protocol, or manuscripts, or designing trials. This is a role with an incredible diversity of responsibilities and work types--perfect for precepting a student!

Day 2 and Beyond:

Typical days worked like this: I could arrive anywhere between 6 and 9 AM, staying until 3 to 6 PM. I was issued a company laptop that allowed me to work from home provided I had no in-office responsibilities (though I always cleared these days with my preceptor). I opted to arrive early and leave early to avoid the minimal traffic that Indianapolis developed along my route.

The work environment is highly interdisciplinary and they use an open-office environment. With your laptop you can sit more-or-less wherever you would like, lock into a dock (with a large screen and peripherals) and work there all day or move around. Few people have permanent desks but there is tons of space to sit a group around a table, and space to work alone for a while if you need to as well. I was struck by walking down the halls and overhearing conversations by engineers, pharmacists, statisticians, physicians, PhDs of all flavors, and more!

My major projects could be summarized as follows:

Safety Monitoring or Other Reporting:

As I have a computer science background, I asked for data-centric projects where possible. I was routinely given blocks of data to crunch and provide recommendations. Usually, this was blinded adverse event data from a trial. With pivot tables and a little VBA these usually went quickly. Other reporting included analyzing concomitant medications and correlating those with outcomes, or doing demographic breakdowns for relevant groups. Notably, one project had me examine the different subtypes of cancers in these trials and examine the rates and locations of metastasis and correlate these with other relevant biomarkers--are there patterns? Are these in-line with literature, if it exists? Clinical trials are valuable sources of medical knowledge even outside the medication they are testing--we've learned a lot!

Medical Information and Writing

A major responsibility of the CRS is medical writing--whether that be trial manuscripts, clinical study reports (a data summary of a clinical trial), or communication with healthcare providers. I was tasked with authoring a manuscript for a Phase I dose-escalation trial that had not yet made it to publication. I had the opportunity to dig deep into a clinical study report, learn a disease-state inside and out, and work with the primary investigators (physicians and pharmacists) to report what they had found. When I left, the study was squarely in the hands of the medical writers who were polishing and editing the final draft!

As part of the CRS role, my preceptor received anywhere from 5-10 eligibility or clinical questions from the research sites worldwide. He passed many of them on to me, where I was responsible for evaluating their question, examining the protocol and literature where appropriate, providing a recommendation, and drafting a response.

Protocol Authorship

My final major project was built around a handful of pre-clinical compounds that Lilly had been working on for some time. They targeted a genetic mutation that is believed to drive the growth of several cancers. It was left to me to examine the literature and define where the greatest unmet medical need existed; meaning which cancers lack available treatments and have high rates of mortality (e.g. pancreatic cancer) versus a cancer that the mutation might be less common in, or the cancer has powerful existing therapies available. This was much more complicated that I initially expected, given that even identifying people with the mutation consistently was a problem. What assays should we use and how do they work? There were over a dozen methods that were not correlated with each other, and then attempting to work out how they correlated with outcomes was another hurdle.

This culminated in authoring a protocol synopsis: taking everything I had learned and transforming that into a study summary including information like: what cancers, who are we targeting, how do we identify them? What inclusion and exclusion criteria should be used to that effect? What are the treatments we'll use? What study design? What endpoints will be used and how are they measured? And much, much more!

Other

Lastly, Lilly has a structured program for visiting P4 students where you will meet dozens of practicing pharmacists from roles all over the company. There were usually 2 or 3 weekly, plus any other one-on-one meetings that you could schedule anywhere you'd like. One of the pharmacists works in the manufacturing facility, so we got a tour and saw how many of their drugs are made! Incredible to see!

I had a wonderful time at Lilly, and now there are even more opportunities to go! I hope this gives you a good idea of what I did while I was there--I definitely learned that this is where I want to end up!

Michael Harrison (mhar)




Sunday, December 20, 2015

Rotation 6 - Refigerator Malfunctions, Life on Hold, and Other Stories

Posted by E. Caliman at Sunday, December 20, 2015

I spent Rotation 6 at the University of Michigan's Drug Information Service. This mainly consisted of working on a couple of assigned projects while fielding calls from various U of M practitioners. Some were quick fixes that merely required reading a medication's package insert, while others required consulting multiple resources to discover the answer. Unfortunately, there is not a lot of data out there for some questions and the best answer you can give is "We couldn't find any data on your question. Use clinical judgment".

One of the more frequent types of calls we received were storage conditions of medications requiring refrigeration. In a few instances, we had some malfunctions that allowed the medications to go on excursions outside their specified temperature. This required calling the manufacturer for information on what the stability is outside of the recommended range. This meant spending a lot of time on hold. We learned to dread calling one particular manufacturer because in order to get the information, we need the expiration date and lot number of the affected products, whereas other manufacturers could provide blanket data.

Calling manufacturers for other reasons resulted in substantial hold times. I got used to listening to hold music, which was mostly smooth jazz or classical music, but one manufacturer in particular played country music, which surprised me. One manufacturer I had to call a couple of times had no hold music, so I sat at my computer, listening to silence. The best you can hope for in these instances is that you navigated the menu tree correctly so you wouldn't be transferred all over the place to someone else who would tell you that this was the wrong department and transfer you again.

There were some interesting stories we encountered in the call center. One was involved a patient's medication by a certain manufacturer no longer being approved by his mail-order pharmacy, so we looked into other generic manufacturers, guided by the site of manufacture. Another involved calling a manufacturer for information on an adverse event that limited the functional capabilities of a patient. Finally, another medication had a temperature excursion, but it was in a patient's home. It was a very expensive medication, but thankfully could remain stable for long enough that the patient could finish it.

Our longitudinal projects included filling out Medwatch reports, where you report adverse events to the FDA. We thankfully only had a few to fill out this rotation. It involves going into the patient's electronic medical record and gathering the necessary data for the form. The other project was a drug monograph, a summarizing report on a particular drug. The ones we were assigned were newly approved by the FDA, but were waiting approval to the U of M formulary. This project involved reading the package insert, looking at prices, and reading clinical trials.

This rotation was a bit more laid back, which is nice when you're trying to prepare for the next stages in your career, including job, residency, and fellowship interviews, attending ASHP Midyear, and finalizing your research paper.

Tuesday, August 25, 2015

Rotation 3- Community: Still Going Strong

Posted by E. Caliman at Tuesday, August 25, 2015

I'm doing my Community Rotation at a local compounding pharmacy. I enjoyed compounding during P1 year and was interested in it even before starting pharmacy school. After the fungal meningitis outbreak from the New England Compounding Center in 2012, I thought that a community compounding pharmacy would be a nice, slower-paced rotation as compared to a chain community pharmacy.

I was wrong. I was so very wrong.

Compounding pharmacies are very much alive and well, even with piles of restrictions and new regulation. It's likely due to the fact that compounding pharmacies provide patients with medications they can't find at a regular community pharmacy and the personal level of service because many of them have fewer patients.

Slow days here are few and far between. I started off on a week where almost 100 scripts were filled each day. It's always busy. If you're not filling, you're probably tackling the pile of drug information questions patients and doctors call you about, from drug stability of compounded medications, to drug interactions, to helping them navigate insurance issues, since many insurance companies no longer pay for compounded medications.

Naturally, I got to spend time in the compounding lab. The pharmacy can compound capsules, suspensions, topical creams, ointments, lotions, suppositories, as well as sterile products. I got to try a little bit of each. The experience was more automated than I expected (there's a machine that mixes the topicals and you don't fill capsules by hand), but a little more labor intensive than P1 year would have you believe. Even so, I still enjoy compounding and it's still a career option.

Some of my other projects include updating policies and forms, as well as doing research into regulation and new business opportunities. I researched how a pharmacy in the partnership could provide a new service for the county and updated a privacy practice form to reflect that the pharmacy could now text patients with their permission. Overall I had a great experience and am looking forward to the next rotation.

Friday, July 24, 2015

Meetings, Meds, and Monographs: Drug Information Rotation

Posted by Stephanie Burke at Friday, July 24, 2015


Already done with rotation 2 – time flies! I had my Drug Information (DI) rotation these past 5 weeks, and I learned a ton! I’ve got a pretty good grasp on where to find information for different types of DI questions. The questions I received ranged anywhere from ‘what are the clinical manifestations that could result following accidental injection of a nasal solution of drug A’ to ‘can drug X be crushed and flushed through a G-tube’ to ‘we have a patient who is allergic to sulfites – can you review the ingredients of the attached list of medications for presence/absence of sulfites?’ Not your typical, everyday stuff, but now I have some familiarity with the types of clinical questions that could arise and where I could look to find information. I consider it a great skill to have acquired early on in my rotation schedule.

In addition to answering phone calls and emails from the inquiring minds of our UM providers and researchers, the DI folk also attend a number of different committee meetings. On this rotation, I went to committee meetings for anesthesia, cancer, pain, inventory, and glycemic control. It’s great having our DI pharmacists present because they bring a solid understanding of the available literature, and the meetings help the DI staff stay up-to-date on new information. My personal favorite was the Glycemic Committee meeting given my interest in diabetes mellitus. There was a monograph presentation on Afrezza, the newer inhaled insulin product, and also a discussion on the concentrated insulins that have been surfacing in recent years. Lots of cool stuff in my opinion!!! My hope is to continue attending these monthly meetings in future rotations when I am back in Ann Arbor (out of area rotation 3). If that is the case, I’m sure you’ll see more fun stuff on that in future posts J

One of my other favorite components of this rotation was the monograph project (or in my case, 3 total monographs!). The monographs I prepared will be presented at future Pharmacy and Therapeutics Committee meetings for consideration for formulary addition. The first drug assigned to me was mifepristone. This is a very interesting (and controversial) medication. Used as an investigational drug since 1985, mifepristone was FDA-approved in 2000 for termination of pregnancy through 49 days gestation. The drug had already been adopted in a number of European and Scandinavian countries prior to its approval in the United States. The brand name for this indication was MifeprexTM, produced by Danco Laboratories. Twelve years later, mifepristone was approved for another indication – management of hyperglycemia in patients with impaired glucose tolerance or type 2 diabetes secondary to endogenous Cushing’s syndrome. This brand, KorlymTM, was produced by Corcept Therapeutics. Same active ingredient, two different brands, indications, and manufacturers. Take a look at the pharmacology of mifepristone to see how it could work for two very different conditions!

The third monograph I wrote was for U-300 glargine (ToujeoTM). Again related to diabetes, it was of significant interest to me. The clinical trials that Sanofi-Aventis completed showed, overall, that U-300 glargine was non-inferior to Lantus in blood glucose control, and in some cases, produced less nocturnal hypoglycemia. There were no significant differences in adverse effect profiles between the two. The primary concern we see with adding U-300 glargine to formulary is safety. There have absolutely been medical errors when someone draws up the concentrated product thinking it’s the unconcentrated, or a provider fails to correctly calculate the volume needed given the number of units of insulin. Many things could go wrong here when used in the inpatient setting. For those unaware, insulin is a high alert medication, and there must be effective and appropriate protocols in place to ensure safe use of insulin products.

Drug Information was an excellent experience. It challenges you to dig deep into the inquiries that come in, and also to consider all the data you’ve gathered and make a clinical recommendation. The rotation also better familiarizes you with drug information resources which will be invaluable to any type of work that you do.

 

Tuesday, July 21, 2015

A DI Rotation: Drug interactions? No, Drug Information!

Posted by H. Tran at Tuesday, July 21, 2015

We are in our last week of our second rotation. I’m currently on my Drug Information rotation in Ann Arbor and it’s been a great experience. My daily tasks have revolved around sharing phone duties with another P4 student, which entails answering drug information questions that come in. These questions could come from anyone -- nurses, physicians, pharmacists, psychiatrists, etc., and could be about anything.  Some of the more interesting ones I’ve received were questions regarding appropriateness of using medications off-label (not FDA-indicated). For starters, a psychiatrist inquired about using N-acetylcysteine (NAC) for an autistic patient’s aggressive behavior who had experienced tardive dyskinesia (adverse effect) from their risperidone.  Specifically, they were asking if NAC would cause problems for this patient.  Another interesting request I had was to find a recipe to compound a topical cream of paromomycin for cutaneous leishmaniasis.  You are probably thinking, “Paramo—leishmani—what?!” That was exactly my reaction.

To address these questions, the first thing I did was review the patient’s charts to assess appropriateness of the requested therapy given the patient’s medication list and medical diagnoses. The review includes side effects, kidney/liver function, drug interactions, and any other precautionary measures that would ensure safe and efficacious use of the therapy. I then referred to the literature to support any responses I would provide the requester. Because these therapies were off-label uses, the literature would be the most appropriate resource to support my response. NAC is FDA-indicated and routinely used in case of acetaminophen overdoses, but luckily, NAC has been recently studied for neurologic disorders. I pulled the evidence from the literature and provided the articles to the requester for him to make his own clinical decision based off the outcomes from these studies. From a pharmacy standpoint, I acknowledge whether or not a therapy is appropriate given a medication and problem list. Once I’m ready to make my response/recommendation, I bring it to my preceptor to sign off on, and away it goes!

The request for a recipe was a little more difficult.  Paromomycin is an antibiotic that isn’t on formulary where the requester is situated.  It comes only as a capsule formulation, so finding a recipe was a challenge. Through a literature search, I found a military-based recipe that I provided the requester.  Topical paromomycin is so uncommonly used that it came down to utilizing a recipe that one doctor created for military use. Some of the other drug information questions I received were related to drug stability, drug interactions, if a drug would be safe for a given patient, and alternative therapy options.

When I’m not on phone duty, I work on various projects.  My main project is to create monographs of new drugs that are/may be considered for formulary. I give a rundown of the drug (general description, indication, mechanism of action, side effects, costs, clinical studies, etc.) and compile it all into a monograph.  The drugs I’m working on are ivabradine and combination product sacubitril/valsartan, which are new heart failure medications. The ivabradine monograph will be presented at the Pharmacy and Therapeutics Committee meeting for review of approval and addition to formulary, while sacubitril/valsartan has a novel mechanism of action that will likely be considered for addition to formulary as well. Separately, I also looked into revising guidelines on ketamine use in the emergency department. I surveyed policies and guidelines from various institutions across the nation and compiled the data for the pain management committee to review.

All in all, I never thought drug information was like this. It’s something new every day with different questions for you to problem-solve through. Whether or not you’re interested in drug information, the skills you develop in efficient navigation of references (and knowing what references to use!) would help pharmacists in any setting. I’m glad I had this as my second rotation as it has already made feel more comfortable and efficient in searching through references and studies for answers during my future rotations.

Thursday, June 18, 2015

Rotation 1: The Infamous Stay-At-Home Rotation

Posted by Unknown at Thursday, June 18, 2015

My first rotation was drug information.  I’d heard a lot about this rotation, so I was very excited to begin!  I was at a company that provides clinical information for users, and my focus was primarily on drug-drug interactions.

A Typical Day
I started the rotation mostly editing existing monographs and performing quality assurance on monographs that had not updated recently, but I gradually took on more responsibility and began writing more new monographs.  Requests for new monographs generally came from internal (other departments) or external questions, updated product labeling with new interactions, or articles that my preceptor or I happened to stumble across when researching another topic.  Two or three times a week, my preceptor, the other P4 on my rotation, and I would meet at a coffee shop (yum!) to talk about our work, discuss therapeutic topics and the drugs we were working on, research and writing strategies, and talk about life as a pharmacist.

I Didn't Just Write for 25 Days Straight
I didn’t just sit at home writing all day.  We had a Journal Club midway through the rotation, which was my first JC experience.  I also had the opportunity to poke around a little in the informatics side of the company and see where my monographs went once I finished writing them.  I was also able to work on a few pharmacogenomics projects and give recommendations based on my research, which I eventually wrote into a very different type of monograph.  In addition, I worked on a rotation-long project categorizing drugs based on levels of evidence.

Dusting off the MedChem
I unexpectedly found myself constantly challenged finding mechanisms of action, drug metabolic routes, and using this information to figure out how two drugs interacted with each other.  Some interactions were fairly obvious or were spelled out in a study or drug label, but others were not as clear and needed to be deciphered based on studies with other drugs or in vitro studies.  A few interactions had no evidence whatsoever, and the mechanism was left as “unclear, but the following mechanisms have been ruled out.”  I learned a lot about how drugs could interact, even in the strangest, most roundabout ways.

A lot of what this rotation boiled down to was writing, research, and coffee, which are three things I’m very fond of.  However, there were also many non-writing opportunities, and I was challenged in ways I didn’t expect to be challenged, most notably utilizing all of the medicinal chemistry I had tucked away in my brain a few years back.  If you like to write, I would highly recommend this rotation! 

Tuesday, April 22, 2014

Using a Lifeline: Drug Information

Posted by Adam Loyson at Tuesday, April 22, 2014

With the end of the semester approaching, final exams on the horizon, and commencements just around the corner, I write to you about my exciting tour on rotation with drug information (DI).  On this second to last rotation, I made sure to put in extra effort and learn as much knowledge as possible before my chapter as a student pharmacist later comes to a close.  I also continued to grow my skills in conducting systematic searches for information and providing clear and concise evidence-based answers to a variety of healthcare professionals.  Routine day on rotation you say?  Definitely not!  There were so many more opportunities to get involved while working in DI, some of the most rewarding I elucidate on below. 

The Basics
Today, there is an abundant amount of health information on the internet with much of it sketchy at best.  DI services, therefore, are a valuable resource to provide accurate and quality information in a timely manner.  The Drug Information Service I worked with while on rotation was responsible for servicing a tertiary healthcare center comprised of an adult hospital, a children’s hospital, 120 outpatient clinics, and 40 health centers, comprising a total of over 900 patient beds.  In addition, the service also provided pharmacotherapy consultation services for practitioners in southeastern Michigan.  The DI call center’s volume was rated at approximately 1,800 questions annually.  While on rotation, I had the opportunity to explore and find answers to the most common questions (medication’s therapeutic use, pharmacokinetics, dosing, drug interactions, toxicity, pregnancy/lactation use, compatibility, shortage availability) to the more extraordinary inquiries (homeopathic use, tapering regimens, stability in refrigerator/freezer outages, compounding regulations).  To answer effectively, I participated in weekly topic discussions and evidence-based medicine assessments to review most helpful DI resources, including those found online.
Of the more interesting requests during rotation, I was tasked to find out more on the use of oseltamivir in national strategic stockpiles, specifically the proper emergency preparedness handling of expired medications.  As someone hoping to enter public health after graduation, this was right up my alley!  After contacting the Food and Drug Administration, Centers for Disease Control, and my state’s community health department, I discovered that select lots of oseltamivir may receive extensions to their expiration dating via FDA announcement in emergent times of natural disaster.  Another interesting request came from a transplant pharmacist wanting to know more about the bioavailability and safety profile of magnesium treatments complexed with protein.  Early studies demonstrate more patients tolerating this organic chemical identity as compared to magnesium oxide.  I also found that larger trials were currently being conducted by the manufacturer, who agreed to send my institution notice as soon as they were published.

More than just an Operator
While answering drug information requests was a primary responsibility, I also participated in numerous projects associated with the Pharmacy and Therapeutics (P&T) committee, ambulatory infusion formulary committee, the cancer pharmacy committee, and the product and vendor selection subcommittee within the health system.  As the opportunity presented, I completed a P&T drug monograph on a monoclonal antibody aimed at inducing remission for those with ulcerative colitis and Crohn’s disease.  I also completed several MedWatch reports detailing drug adverse events and wrote a newsletter article to be sent out to the entire health system outlining the new guidelines released by the US Public Health Service detailing HIV post-exposure prophylaxis in occupational healthcare providers.  Of high value to the health system, I concluded my rotation by finishing a medication use evaluation on intravenous immunoglobulin to ensure proper ordering and dispensing of this extremely expensive blood product to patients.

Fuel for the Future

DI was just the rotation I needed to boost my skill set and confidence.  I now task other healthcare providers and students to give me their best shot.  If I don’t know the answer, I’ll know where to find it.  With another rotation completed, I continue on my path to being a professional with newly learned integration and collaboration skills necessary to help in determining the most appropriate course of action in a given healthcare situation.

Wednesday, January 8, 2014

Who You Gonna Call? Drug Info!

Posted by Rachel Lebovic at Wednesday, January 08, 2014


While I don’t want to become a drug information pharmacist, my drug information rotation at the Ann Arbor VA was a worthwhile experience. When any health care professional in the Ann Arbor VA doesn’t know the answer to a medication-related question, they have the opportunity to call the drug information pharmacist (my preceptor, Dr. Ed LaHaie). Most often, the physician, nurse, or pharmacist with the question already looked at a few drug information resources and either couldn’t find the answer or found conflicting information. Then, it was my turn to delve deeper into drug information resources, primary literature, and/or call the manufacturer to try to answer the clinician’s question.

I received a wide variety of questions during my time at the VA. For example, one practitioner asked if losses in word-finding ability have been reported with gabapentin, a medication often used in diabetic neuropathy. A pharmacist called to ask if there were any clinically relevant drug interactions between a patient’s current medications and konjac root, an herbal product reported to lower cholesterol and stimulate weight loss. A physician wondered if alendronate, a medication for osteoporosis, would be absorbed in a patient whose stomach had been surgically removed due to gastric cancer. Yet another clinician asked if there were data to support the use of mifepristone, an abortifacient, in patients with Cushings disease. After responding to these questions and many more, I feel I have a better understanding of which references are best suited to answer different types of questions.

In addition to answering drug information questions, I also wrote a new drug monograph and prepared an hour-long presentation to the pharmacists at the VA. My new drug monograph explained the efficacy and safety of vortioxetine, a new anti-depressant medication. One of the most time-consuming but educational parts of the monograph was the appendix, in which I created a detailed chart comparing the data from eleven clinical trials that studied vortioxetine. The hour-long presentation I created on this rotation was titled, “Update on the Management of Crohn’s Disease.” Since I am interested in teaching pharmacy students as part of my career, I enjoyed the process of researching a topic and developing an engaging presentation that I thought the audience would find useful. I was proud that the pharmacists in the audience seemed interested in the presentation and asked pertinent questions.

Lastly, throughout this rotation I gained insight into some of the administrative roles a drug information pharmacist might have. My preceptor, Dr. LaHaie, approves (or denies) all of the non-formulary drug requests for the Ann Arbor VA. Non-formulary medications are those that are not allowed to be ordered for a patient, unless the patient’s case warrants special approval. I enjoyed discussing some of these non-formulary drug requests with my preceptor because they frequently involved interesting ethical dilemmas. Dr. Lahaie also serves on the Pharmacy and Therapeutics (P&T) Committee and the Drug Shortages Committee at the VA, so I was able to attend these meetings and gain insight into the decisions and work that goes on behind the scenes to determine which medications will be on the formulary and ways to work around drug shortages.

In all, I gained valuable experience during my drug information rotation at the VA. I missed seeing patients and I still think I am better suited for a clinical specialist position on an inpatient multidisciplinary team, but the drug information skills I developed will help me be a better clinical pharmacist.

Monday, January 6, 2014

"Drug Information Service, How Can I Help You?”

Posted by Silu at Monday, January 06, 2014

Happy New Year, everyone! P4s, the mysterious year of graduation is upon us…2014! It has definitely been a busy two months with rotations, the Midyear meeting and residency applications. The past few weeks was a much-needed break. 

I was excited for this rotation at the Drug Information Service at U of M to learn about using resources to their full potential and answering questions from all parts of the health system. In the end, drug information taught me much more than just that.

The student’s responsibilities for this rotation include running the phone- and email-based drug information service, attending P&T and sub-committee meetings at the hospital, two major projects (a drug monograph and another writing project), a newsletter article, and other small assignments that may come up.

Answering questions was my favorite aspect of the rotation. A wide variety of questions came to us, from the outpatient clinics asking for antibiotic selection to UMHS pharmacies in search of compounding recipes and medication formulations to physicians inquiring about potential idiosyncratic drug reactions. UM Drug Information Service has a comprehensive collection of books, online databases, and internal resources…it was definitely a nice privilege having ease of access to these resources. The meetings we attended gave a unique insight into behind-the-scenes operations. It was empowering to see excellent pharmacy representation at both P&T and interdisciplinary committee meetings.

Of all of the duties we were assigned, the projects ended up being the most challenging aspect for me. I felt confident about my ability to complete these assignments well. However, both my projects turned out to be larger in scope than I (or my preceptors) had imagined. My first writing project regarding IV acetaminophen for post-operative pain was complex and had a much sooner deadline than anticipated along with several points of follow-up based on changing circumstances. My monograph of an ophthalmic preparation of an antiviral drug used for a very specific disease also included a cross-country search for an ophthalmic recipe and writing an informed consent. At first, I was surprised by the scope and constantly changing demands of these projects, but realized in the end that this was, after all, real life. For my preceptors, new situations and different opinions can change the direction of their work, just as it did with mine. This challenged my ability to prioritize and manage my time around meetings, assignments, and an unpredictable volume of phone questions. In the end, I appreciated that I was immersed in real work of a drug information pharmacist rather than simplified student work.  

Overall, I am thankful for all I have learned at Drug Information and for the opportunities to make a difference to improve patient care on a different level through the work I accomplished.

Stayed tuned for the next rotation …o wait…I am off! See you in February for community pharmacy.  

-Silu

Tuesday, October 9, 2012

Anna in pajamas – a rotation at Lexi-Comp, Inc.

Posted by Anna at Tuesday, October 09, 2012



I just finished my fourth rotation: Drug Information with Lexi-Comp, Inc. As the title implies, this rotation has an open dress code as the bulk of the work occurs at home. It was great to take that white coat off for five weeks, but don’t let the cozy working situation fool you—this was a challenging rotation with high expectations.

I had the honor of reuniting on rotation with one of my colleagues, Katrina. Our preceptor, Dr. Dan Streetman, is one of the pharmacists responsible for the interaction database for Lexi-Comp (among his other responsibilities). This was the main focus of our rotation, which meant a lot of CYP interaction review! Essentially, Dr. Streetman makes sure the interactions reported by Lexi-Comp are up to date and accurate, and he also fields questions directed to the interactions team. For five weeks Katrina and I did our best to do the same!

A perk of this rotation is flexibility in your schedule. Your hours can be whatever you want them to be, as long as you get your projects done and make sure to get in (at least) 40 hours of work per week. Due to the nature of this rotation, my laptop became my new best friend. I would search for information, read the literature, come up with my own interpretation and recommendations, and type up a summary of what I found. This was a less traditional take on a drug information experience, as I never directly communicated with other health care providers regarding patient specific questions; however, I did have the chance to answer questions posed to the interactions team. Some of these questions included:

·         Is there any data regarding an interaction between digoxin and proton pump inhibitors—specifically long-term use of PPIs?
·         Should gadobenate have any QT interactions and/or be listed in one of the QT-prolonging groups? If yes, which risk-category? 
·         What interactions need to be added for Stribild, a newly approved drug?

Other basic daily tasks included creating new drug interaction monographs, updating old interaction monographs, journal club, and working on a longitudinal project that involved herbal-drug interactions.  We would also meet with Dr. Streetman twice a week to go over our pending projects and get grilled on our therapeutic knowledge.

Overall, I learned many things on this rotation. I had the opportunity to delve deeper into the mechanisms of drug interactions and the questions that pharmacists face when analyzing literature for true interactions. I gained confidence in my ability to evaluate the primary literature and make my own conclusions regarding the data. I also discovered that working from home is not my forte—although I loved my comfy clothes and short commute, the lack of direct human interaction was difficult, and I also felt that since I worked from home I never actually left work.

The fourth rotation was definitely a blur of activity, as I completed my Pharm.D. seminar on the last day of rotation. Already I am two days into my fifth (!!!) rotation—Advanced Institutional Pharmacy at Spectrum Health in Grand Rapids!

Wednesday, September 19, 2012

Drug Information at the University of Michigan

Posted by Alison Van Kampen at Wednesday, September 19, 2012

Well, rotation number 3 is over, and I had a blast.  Most people will tell you before P4 year starts that Drug Information is a boring rotation, but I must beg to disagree.  I found this to be a really fun rotation that really suited my personality. 

The environment was very low key, which I like, and it didn't hurt that we had lots of space to work as opposed to being crammed down in B2 and fighting to find an available computer.  It also helped that all of the people in the Drug Information Service were great to work with (and I'm not just saying this because I know that they will be reading this post).  My primary preceptor was Dr. Stumpf and I also spent a lot of time with Dr. Bazzi, Dr. Dasse, and Dr. Sweet.  In addition, my fellow student, Matt Perez, and I spent a lot of time with the new resident as wekk. Everyone was very nice, they were helpful when I worked on projects and answered question, and they gave some pretty sound advice for the future.

I found the tasks and projects that we were assigned to be helpful, interesting, and often challenging.  Everyday we were responsible for taking a phone shift.  On the phone shift we would take calls from various people regarding unusual drug questions.  Questions would come in from everyone from physicians, pharmacy faculty, nurses, outpatient pharmacies, and lay-people. The majority of questions had to do with stability of a drug that was left out of the refrigerator (which often resulted in a long call to the manufacturer) but other questions were very interesting and required extensive research.  Here are just a few:

Is it safe to use sedative hypnotics in a patient that has insomnia related to Lewy Body Dementia? and if so, which ones?

Why is it that for all SSRIs, increased risk of bleeding is listed as an interaction with Clopidogrel, but fluoxetine has the added interaction of decreased efficacy of fluoxetine? What is different about fluoxetine?

Should a woman taking medications that compromise her immune system avoid contact with her grandchildren who recently received a live varicella vaccine? and if so for how long?

Are there any concerns, other than lack of efficacy, for a 14 month old patient that was being administered expired CellCept for the past 2 months?

In addition to answering these questions, we also had small projects like filling out MedWatch forms, learning about and determining the pros and cons of various sources of information (there are way more out there than you can imagine), finding ways to critically evaluate journal articles and the statistics they publish, and attending meetings at the hospital.  

We had two larger projects as well.  One was writing a newsletter article, mine was about the possible association between maternal use of SSRIs during pregnacy and Persistent Pulmonary Hypertesion of the Newborn, which was pretty cool.  The other large project was creating and delivering a P&T presentation on a new drug to the Drug Information staff.  This was exciting because I got to research and learn everything about a new drug, Carfilzomib, and learn more about the disease state that it treats, multiple myeloma.

Overall, I really liked this rotation.  There was very little patient interaction, which was good and bad.  Also because I'm not good at being put on the spot, I really liked that I was able to thoroughly research my answer to a question before delivering an answer. AND I was able to learn a lot of interesting and unsusal things about drugs (interesting and unusual has always been very attractive to me).  I would definitely recommend this site to anyone for their Drug Information Rotation.

Friday, February 3, 2012

DRuG InFo

Posted by Melanie at Friday, February 03, 2012

My January Rotation was Drug Information (DI) at Michigan House. I really had a great time on this rotation and could see it as a potential career in the future.

The team of pharmacists that work at DI are absolutely amazing. Let me tell you a little about what a DI rotation at the Michigan House was like:

1 -- Phone Shift
The pharmacists take shifts working the phone line. Questions on your shift can come via telephone call, voicemail, fax, or email. When you receive a telephone call you want to make sure that you really delve deep into the question to find out all the pertinent information while you have the person on the phone. For example, if someone calls and asks you, "What is the dose of Magonate?" what would be the next step (HINT::: I just said it!) --- delve deeper!!

Who are you trying to treat? What are you treating? Is she on any other medications (including herbals, OTCs)? What is her magnesium level and what is her goal? What dose are you currently giving her?

From this conversation you learn that the patient is a 7 year old girl (DON'T FORGET TO ASK HEIGHT AND WEIGHT SO YOU CAN PROVIDE A DOSE REC!) who is deficient in magnesium with a level of 1.2 and a goal of 2 and she has been getting Magonate at a certain dose but the practioner is afraid she might be giving her too much.

Now you have a much different picture in your mind than if you had been told you have a 35 year old male who is around the lower limit of normal and would like to take a magnesium supplement.

At DI, you find out what the time sensitivity on the question is and get a callback number or email and then go and look up the information and then call the person back with the answer. Then you have to log the question and answer so if anyone else gets a similar question, they can refer to yours and see what you came up with.

2 -- 10:00 AM Meeting
At this meeting, all the pharmacists (and students) meet to discuss the previous day's questions. This helps the pharmacists become aware of the questions that were asked, and it also gives an opportunity to bounce ideas off of each other. Like many other times in pharmacy, there isn't always ONE correct answer but multiple acceptable answers. This meeting allows the pharmacists to share how they might have answered the question differently.... this is especially the case for some ethical questions that arise (IE - A parent calls because he found pills in his 17 year old daughter's room --- do you identify the pills for him?).

During these meetings, the students also learn about different references that are available to find certain types of information. Thing of a short EBM course review.

Students on the DI rotation also complete two MedWatch forms, which is reporting adverse events to the FDA. They also complete a P&T monograph and give a presentation on that to the pharmacists. In addition, students write an article for the UM Newsletter.

Saturday, December 24, 2011

Drug Info at DMC

Posted by Elizabeth Kelly at Saturday, December 24, 2011

Christmas Eve... a wonderful time to avoid the tradition of watching boring tv with the family and instead blogging on this past months rotation. So, I was at the DMC with Dr. Margo Farber getting information about drugs this whole past month. And even though the rotation was technically very boring, I actually learned a lot and utilized my time very well.

Typical day:
Get there 8:30-9. Spend forever getting settled in, check my email, finally settle in and get working on a drug monograph or whatever miscellaneous drug information question that was given to me by Dr. Farber or one of the other drug information specialists.
Sometime during the day go to a meeting or lecture... note they have a lot of free food on this rotation. You probably only need to buy/bring a lunch only half the days if you play your cards right. And they have a subway right on the floor above...healthy eating!!!
Leave after 8 hours of course......................................

How I made this rotation fabulous:
1) I knew I was applying to the DMC residencies so I introduced myself to as many "big-wigs" as possible and Dr. Farber really facilitated that.
2) Asked to shadow different pharmacists... got a great experience for the other student and I in the anticoagulation clinic.
3) Made a point to learn about the material that I had to research. Might as well... I have boards to pass in a few months.
4) Dr. Farber is a great preceptor and really made an effort to teach us pertinent information and guide me in my residency search (she is even writing me a letter of rec!).

There are a few pains with this rotation:
1) Distance from Ann Arbor (although that didn't matter to me since I live at home in St. Clair Shores)
2) You have to park way away from the hospital and either take a shuttle or walk (note... if you have this rotation it is WAY faster to walk from the hospital back to the Bethel church parking lot then it is to wait for the bus... even if it is sitting right there waiting for you).

Now, if anyone has any questions about this rotation feel free to email me!

Sunday, November 13, 2011

Drug Information: Lexi-Comp

Posted by Eric Zhao at Sunday, November 13, 2011

This month, I'm excited to help write for a drug information program known for both its online and mobile platforms:


I'm looking at you, Lexi-Comp

Working with a previous University of Michigan College of Pharmacy alumnus as my preceptor, I help write and update drug-drug interactions for the program. Some examples of the interactions are those between carbamazepine/non-dihydropyridine calcium channel blockers, levodopa/iron salts, and oxcarbazepine/phenytoin, among others.

The Process
1. Initial Search:
The initial search involves a very broad query in PubMed for the interacting drugs, and if there are a reasonable number of hits (around 200 or less), we begin screening abstracts for possibly pertinent articles. Sometimes the query produces over several thousand results, so we employ alternative search strategies (e.g., using limits, excluding "review" articles, etc.).

Some sort of national database

2. Screening:
After combing the abstracts, I can usually narrow the article list down to about a quarter of the original number. Here's where I access and skim the articles to see if they will be useful for the write-up. This narrows the list down even further.

3. Write-up/Update:
Once I determine which articles will be useful for an evidence-based write-up, I determine a strategy. Ideally, my final list involves articles that provide many different viewpoints of the drug interaction, which include primary literature and case reports. After thoroughly analyzing the articles, I begin writing the drug interaction monograph.

4. Upload: Prior to uploading, I review my drafted monograph with my preceptor for his opinion and expertise. If all goes well, my preceptor will remotely log-in to the database and upload our monograph. It's pretty neat to see the immediate changes on my phone's Lexi-Comp application after uploading.

This rotation allows me to practice my literature searching skills while providing a lot of autonomy. My preceptor gave me several projects that he wants finished before the end of rotation and it's up to me to prioritize and deliver (i.e., I set my own schedule). During our meetings, I inform him of what I have been working on, and he lets me know my progress. That said, I'm going to get back to my projects.

-Eric Zhao

Monday, November 7, 2011

Chugging Along

Posted by Matthew Lewis at Monday, November 07, 2011

First, I want to clarify something that I may have confused some people about. The Ann Arbor VA does have residency spots open for next year (2012-2013), and many of my classmates are quite serious about doing residency at some VA, either in Michigan or across the country. It's just that this current year there are no U of M grads as residents and all the current residents expected to have a Wolverine present due to our proximity. This coming year I'm sure we'll have at least one because of all the interest in the program and the Ann Arbor VA being a good fit.

Moving along, it's beyond the halfway point and I'm still feeling pretty good. I'm working on my projects and answering drug questions along the way. I feel pretty confident that most questions you will see on drug info has to do with "off label" indications or non-formulary drugs. As my preceptor explained, the doctors and nurses have more access to drug information from things like their iPhone or Blackberry than they ever had before.

Another thing I learned is that every pharmacist has their own way of practicing with their own habits and favorite drugs. It came to my attention for non-formulary drug requests, where doctors make their case for pharmacy to supply something that may cost more or be last line therapy for a patient. My preceptor does not like to approve particular tube feeding formulations without exacting data which shows a clear benefit which must be a better clinical outcome like going home earlier. On the other hand, he is more lenient with appetite stimulators for cancer patients. He's not a hypocrite since he does get data for both things, but in any evaluation, there is some subjective clinical decision making process that must go on. It'll be interesting to see when I practice what issues will be things I go on crusades for or against and what type of drugs I favor and try to avoid while keeping in mind the care the patient needs.

Tuesday, October 25, 2011

It's Not Boring, I Swear.

Posted by Matthew Lewis at Tuesday, October 25, 2011

Hello Readers.

I'm already in the groove for my newest rotation, which is drug info. This is my second rotation in the Veteran's Affair group of hospitals, but there is a huge difference between the hospitals, and I think that is because of financial support. For example, the Detroit VA does not have a residency program but Ann Arbor (and Battle Creek) do.

[As a side note on residencies, several students from my class hope to be placed in the VA system, but I've been told that there aren't any residencies available at the Ann Arbor VA site this year. This situation isn't unique to VA as the demand for pharmacy residencies continues to outpace the supply
nationwide. That means increasingly intense competition for limited slots. Michigan has one of the highest pharmacy residency placement rates in the country, but being a Michigan PharmD does not automatically make you the preferred candidate for a residency. Landing a residency still comes down to polished interviewing skills and an ability to package your talents in ways that make you stand out from the crowd.]

Back to the story at hand. As I mentioned, my current rotation is drug info. My preceptor, Dr. Ed Lehaie is a great guy and was recognized as preceptor of the year for 1999. The first day was all about getting paperwork in and computer access. I even answered some questions. Today, I answered a few more questions, particularly on replacements for the pain medication fentanyl because there is a drug shortage looming on the horizon. First, I did not even realize there were other drugs in the fentanyl family, so learning about those was interesting. I compared onsets and found appropriate doses through literature searches for sufentanil, remifentanil, and alfentanil. Finally, I did a little cost analysis.

You may have heard about drug shortages in the news, since they have gotten so bad people are dying from not getting proper medications on time. Part of drug information's job is to figure out how to work around these shortages. The other major part of drug information's job is to ... well, dispense drug information. This is usually in the form of approving medication requests that are off-label or extremely costly, such as cancer medications. We will also present new drugs and new research to our pharmacy and therapeutics (P&T) committee, where they can discuss what additional restrictions they want to place on drugs. VA P&T committees are quite different from normal P&Ts, in that each hospital has to follow the nationally mandated formulary decided upon by the national P&T. The local hospitals can only further restrict use.

That's the nuts and bolts of this rotation. I'm definitely going to be getting some weird questions, so I'll keep in touch to share them all.

Tuesday, October 19, 2010

Drug Interactions- Wading through the data

Posted by Sarah Thiel at Tuesday, October 19, 2010

For my third rotation, I have been working on drug information with LexiComp. My preceptor works specifically on all topics related to drug interactions, including writing the monographs seen in LexiInteract.

It can be crazy to think about, but all those useful resources, such as Micromedex, the Drug Information Handbook, and Facts and Comparisons, all had to be written by somebody.

And while as students we may use those resources on a daily basis, it is easy to take for granted the concise and direct nature of the text and all the long hours put into reading the research that is the foundation for such resources.

One of the most valuable skills all students should take away from their drug information rotation is the ability to critically evaluate literature and to be able to consolidate those tens to possible hundreds of pages of research to a concise but thorough piece of writing.

Critically evaluating and reviewing literature is more than "there were some typos and the funding source could have biased the results". You have to dig so much deeper.

For drug interactions specifically, there are many factors that can influence findings. Many of the cytochrome P450 enzymes are polymorphic, resulting in different phenotypes of enzymes. Medications that are classified as "inhibitors" don't all inhibit to the same degree. Concentrations used for in vitro experiments may not represent concentrations seen in humans. Transporter proteins, both efflux and uptake pumps, can also influence magnitudes of interactions.

Then there is the issue of conflicting results: study A found increased risks of poor outcomes from combination therapy of drugs X and Y, but study B found no difference in risks. Now it's your job to wade through the data, the study design, and yes- even the statistical methods, to understand the possible reasons behind the difference in results. Because what would you tell a physician who is asking you, the pharmacist, if they could put a patient on drug Y who is already on drug X? Clearly, knowing how to critically evaluate the literature and explain it to another person in a concise manner can further make the pharmacist a critical member of the health care team.

So despite the hundreds of hours I've spent running PubMed literature searches, reading primary research, writing and revising interaction monographs, I can be assured that I'll never read a research paper the same way I did prior to this rotation.